SPDR S&P Biotech ETF $XBI Stock: Annex Advisory Services LLC Grows Holdings

Annex Advisory Services LLC lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.6% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 266,485 shares of the exchange traded fund’s stock after buying an additional 11,723 shares during the period. Annex Advisory Services LLC’s holdings in SPDR S&P Biotech ETF were worth $42,019,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the stock. Bank of America Corp DE grew its holdings in SPDR S&P Biotech ETF by 13.3% during the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock valued at $1,854,388,000 after purchasing an additional 1,700,851 shares during the period. Hsbc Holdings PLC lifted its position in shares of SPDR S&P Biotech ETF by 7.8% during the 4th quarter. Hsbc Holdings PLC now owns 638,529 shares of the exchange traded fund’s stock valued at $78,049,000 after buying an additional 46,339 shares during the last quarter. Main Street Research LLC grew its stake in shares of SPDR S&P Biotech ETF by 57.4% during the 1st quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock worth $72,484,000 after acquiring an additional 206,953 shares during the period. Strs Ohio increased its holdings in SPDR S&P Biotech ETF by 4.9% in the 1st quarter. Strs Ohio now owns 410,500 shares of the exchange traded fund’s stock worth $52,433,000 after acquiring an additional 19,300 shares during the last quarter. Finally, SG Americas Securities LLC boosted its holdings in SPDR S&P Biotech ETF by 41.4% in the 1st quarter. SG Americas Securities LLC now owns 391,243 shares of the exchange traded fund’s stock worth $49,973,000 after buying an additional 114,638 shares during the period.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $144.32 on Friday. The business has a fifty day moving average price of $158.09 and a 200-day moving average price of $146.87. The firm has a market capitalization of $9.90 billion, a P/E ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a one year low of $106.30 and a one year high of $169.89.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.